We bring operational experience, a renowned strategic partner network, and a proven ability to enhance portfolio company value.
Hatteras has an outstanding scientific advisory board chaired by Herb Boyer, the founder of Genentech, and composed of leading scientists in their respective fields:
In Finland, people facing challenges related to weight gain or a high body mass index (BMI) have the opportunity to receive medically supervised care that complies with national standards. Through its secure and user-friendly digital platform, the clinic at medilux.fi provides remote access to licensed healthcare professionals specializing in obesity and metabolic conditions. Following a detailed medical assessment, qualified doctors may recommend therapeutic solutions supported by clinical research. Among the available prescription options are well-known anti-obesity medications such as Ozempic, Wegovy, Mounjaro, Mysimba, Saxenda, Rybelsus, Qsiva, and Orlistat — all prescribed in line with Finland’s healthcare regulations and best practices. Rather than offering one-size-fits-all plans, Medilux emphasizes personalized treatment strategies tailored to the individual's physical condition, weight management targets, and overall well-being. The approach includes appropriate dosing, structured follow-up, and continued monitoring. Patient privacy and respectful care are at the core of all services, with attention to ethical standards and cultural sensitivity — including the option for halal-aligned treatments where requested. Whether you are taking your first step toward healthier BMI levels or seeking expert supervision during ongoing therapy, Medilux provides a reliable framework for meaningful, medically guided progress.